©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Oct 15, 2022; 13(10): 835-850
Published online Oct 15, 2022. doi: 10.4239/wjd.v13.i10.835
Published online Oct 15, 2022. doi: 10.4239/wjd.v13.i10.835
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
Geza Nagy, Tekla Evelin Szekely, Aniko Somogyi, Magdolna Herold, Department of Internal Medicine and Hematology, Semmelweis University, Budapest H-1088, Hungary
Zoltan Herold, Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, Budapest H-1083, Hungary
Author contributions: Nagy G and Szekely TE wrote the manuscript with the support of Somogyi A, Herold M and Herold Z.
Conflict-of-interest statement: All authors report no relevant conflict of interest for this article.
Corresponding author: Geza Nagy, MD, PhD, Assistant Professor, Department of Internal Medicine and Hematology, Semmelweis University, Szentkiralyi u. 46, Budapest H-1088, Hungary. nagy.geza@med.semmelweis-univ.hu
Received: May 28, 2022
Peer-review started: May 28, 2022
First decision: August 1, 2022
Revised: August 8, 2022
Accepted: September 15, 2022
Article in press: September 15, 2022
Published online: October 15, 2022
Processing time: 138 Days and 16.3 Hours
Peer-review started: May 28, 2022
First decision: August 1, 2022
Revised: August 8, 2022
Accepted: September 15, 2022
Article in press: September 15, 2022
Published online: October 15, 2022
Processing time: 138 Days and 16.3 Hours